Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Braz. j. med. biol. res ; 40(10): 1287-1304, Oct. 2007. ilus, tab
Artigo em Inglês | LILACS | ID: lil-461366

RESUMO

The pharmacology of synthetic organoselenium compounds indicates that they can be used as antioxidants, enzyme inhibitors, neuroprotectors, anti-tumor and anti-infectious agents, and immunomodulators. In this review, we focus on the effects of diphenyl diselenide (DPDS) in various biological model organisms. DPDS possesses antioxidant activity, confirmed in several in vitro and in vivo systems, and thus has a protective effect against hepatic, renal and gastric injuries, in addition to its neuroprotective activity. The activity of the compound on the central nervous system has been studied since DPDS has lipophilic characteristics, increasing adenylyl cyclase activity and inhibiting glutamate and MK-801 binding to rat synaptic membranes. Systemic administration facilitates the formation of long-term object recognition memory in mice and has a protective effect against brain ischemia and on reserpine-induced orofacial dyskinesia in rats. On the other hand, DPDS may be toxic, mainly because of its interaction with thiol groups. In the yeast Saccharomyces cerevisiae, the molecule acts as a pro-oxidant by depleting free glutathione. Administration to mice during cadmium intoxication has the opposite effect, reducing oxidative stress in various tissues. DPDS is a potent inhibitor of d-aminolevulinate dehydratase and chronic exposure to high doses of this compound has central effects on mouse brain, as well as liver and renal toxicity. Genotoxicity of this compound has been assessed in bacteria, haploid and diploid yeast and in a tumor cell line.


Assuntos
Animais , Camundongos , Ratos , Antioxidantes/farmacologia , Derivados de Benzeno/farmacologia , Compostos Organosselênicos/farmacologia , Sintase do Porfobilinogênio/antagonistas & inibidores , Saccharomyces cerevisiae/efeitos dos fármacos , Derivados de Benzeno/toxicidade , Modelos Biológicos , Testes de Mutagenicidade , Compostos Organosselênicos/toxicidade
2.
Braz. j. med. biol. res ; 37(2): 159-165, Feb. 2004. tab, graf
Artigo em Inglês | LILACS | ID: lil-354181

RESUMO

Saccharomyces cerevisiae mutants deficient in superoxide dismutase genes (sod1delta, sod2delta and the double mutant) were subjected to H2O2 stress in the stationary phase. The highest sensitivity was observed in the sod2delta mutant, while the sod1deltasod2delta double mutant was not sensitive. Sod mutants had lower catalase activity (44 percent) than wild-type cells, independent of H2O2 stress. Untreated cells of sod1deltasod2delta double mutants showed increased glutathione peroxidase activity (126 percent), while sod1delta had lower activity (77 percent) than the wild type. Glutathione levels in sod1delta were increased (200-260 percent) after exposure to various H2O2 concentrations. In addition, the highest malondialdehyde levels could be observed without H2O2 treatment in sod1delta (167 percent) and sod2delta (225 percent) mutants. In contrast, the level of malondialdehyde in the sod1deltasod2delta double mutant was indistinguishable from that of the wild type. These results suggest that resistance to H2O2 by sod1deltasod2delta cells depends on the induction of glutathione peroxidase and is independent of catalase, and that glutathione is a primary antioxidant in the defense against H2O2 in stationary phase sod1delta mutants.


Assuntos
Antioxidantes , Glutationa Peroxidase , Estresse Oxidativo , Saccharomyces cerevisiae , Superóxido Dismutase , Catalase , Peróxido de Hidrogênio , Oxirredução , Espécies Reativas de Oxigênio , Saccharomyces cerevisiae , Superóxido Dismutase
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA